Wilmington Savings Fund Society FSB increased its position in Morgan Stanley (NYSE:MS – Free Report) by 474.3% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 21,134 shares of the financial services provider’s stock after buying an additional 17,454 shares during the quarter. Wilmington Savings Fund Society FSB’s holdings in Morgan Stanley were worth $2,203,000 at the end of the most recent reporting period.
Other institutional investors have also modified their holdings of the company. Healthcare of Ontario Pension Plan Trust Fund lifted its holdings in Morgan Stanley by 382.4% in the 3rd quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 1,597,800 shares of the financial services provider’s stock valued at $166,555,000 after acquiring an additional 1,266,600 shares during the last quarter. Fisher Asset Management LLC raised its holdings in shares of Morgan Stanley by 2.7% in the 3rd quarter. Fisher Asset Management LLC now owns 22,404,981 shares of the financial services provider’s stock worth $2,335,495,000 after purchasing an additional 590,872 shares in the last quarter. HighTower Advisors LLC raised its holdings in shares of Morgan Stanley by 71.2% in the 3rd quarter. HighTower Advisors LLC now owns 1,370,572 shares of the financial services provider’s stock worth $140,077,000 after purchasing an additional 569,789 shares in the last quarter. Zurich Insurance Group Ltd FI acquired a new stake in Morgan Stanley during the second quarter valued at approximately $43,850,000. Finally, Erste Asset Management GmbH bought a new stake in Morgan Stanley during the third quarter worth approximately $46,067,000. Institutional investors and hedge funds own 84.19% of the company’s stock.
Insider Buying and Selling at Morgan Stanley
In related news, Director Stephen J. Luczo sold 60,000 shares of the firm’s stock in a transaction that occurred on Thursday, October 17th. The stock was sold at an average price of $119.17, for a total value of $7,150,200.00. Following the transaction, the director now directly owns 138,363 shares of the company’s stock, valued at approximately $16,488,718.71. This trade represents a 30.25 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Corporate insiders own 0.24% of the company’s stock.
Morgan Stanley Trading Down 0.4 %
Morgan Stanley (NYSE:MS – Get Free Report) last issued its earnings results on Wednesday, October 16th. The financial services provider reported $1.88 earnings per share for the quarter, topping the consensus estimate of $1.57 by $0.31. Morgan Stanley had a return on equity of 12.58% and a net margin of 10.64%. The company had revenue of $15.38 billion for the quarter, compared to analyst estimates of $14.27 billion. As a group, sell-side analysts anticipate that Morgan Stanley will post 7.33 earnings per share for the current fiscal year.
Morgan Stanley Announces Dividend
The firm also recently disclosed a quarterly dividend, which was paid on Friday, November 15th. Investors of record on Thursday, October 31st were given a dividend of $0.925 per share. This represents a $3.70 annualized dividend and a yield of 2.90%. The ex-dividend date was Thursday, October 31st. Morgan Stanley’s payout ratio is presently 56.32%.
Analyst Upgrades and Downgrades
Several research analysts have issued reports on the company. The Goldman Sachs Group upped their price target on Morgan Stanley from $106.00 to $121.00 and gave the company a “neutral” rating in a report on Thursday, October 17th. Barclays boosted their target price on Morgan Stanley from $121.00 to $135.00 and gave the stock an “overweight” rating in a research report on Thursday, October 17th. Royal Bank of Canada increased their price target on Morgan Stanley from $108.00 to $122.00 and gave the company a “sector perform” rating in a research report on Thursday, October 17th. Jefferies Financial Group lifted their price target on Morgan Stanley from $120.00 to $135.00 and gave the stock a “buy” rating in a research note on Thursday, October 17th. Finally, Keefe, Bruyette & Woods upped their price objective on shares of Morgan Stanley from $121.00 to $138.00 and gave the company a “market perform” rating in a research note on Tuesday, December 3rd. Eleven investment analysts have rated the stock with a hold rating and six have issued a buy rating to the company. According to MarketBeat, the company has an average rating of “Hold” and an average price target of $121.80.
Check Out Our Latest Stock Analysis on MS
About Morgan Stanley
Morgan Stanley, a financial holding company, provides various financial products and services to corporations, governments, financial institutions, and individuals in the Americas, Europe, the Middle East, Africa, and Asia. It operates through Institutional Securities, Wealth Management, and Investment Management segments.
See Also
- Five stocks we like better than Morgan Stanley
- Investing in Commodities: What Are They? How to Invest in Them
- FinWise Bancorp’s CEO Talks Strategy Behind Fintech Success
- What is Insider Trading? What You Can Learn from Insider Trading
- Broadcom: Turning the Mag 7 Into 8 Trillion-Dollar Tech Giants
- Low PE Growth Stocks: Unlocking Investment Opportunities
- SoundHound AI: Can Its Meteoric Rise Sustain Into 2025?
Want to see what other hedge funds are holding MS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Morgan Stanley (NYSE:MS – Free Report).
Receive News & Ratings for Morgan Stanley Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Morgan Stanley and related companies with MarketBeat.com's FREE daily email newsletter.